Baseline serum Aspergillus galactomannan index in patients with hematologic malignancy and culture-documented invasive pulmonary aspergillosis: Is there a difference among Aspergillus species?

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

It is unclear whether differences exist in baseline serum galactomannan (sGM) in patients with hematologic malignancies and invasive pulmonary aspergillosis (IPA) caused by non-fumigatus Aspergillus species vs Aspergillus fumigatus. We found no differences in baseline sGM positivity rates, median sGM levels, and 42-day mortality in 72 such patients (Aspergillus fumigatus in 43 and non-fumigatus Aspergillus in 29).

Original languageEnglish (US)
Pages (from-to)639-642
Number of pages4
JournalMedical mycology
Volume57
Issue number5
DOIs
StatePublished - Jul 2019

Keywords

  • Aspergillus species
  • Galactomannan
  • Hematologic malignancies
  • Pulmonary aspergillosis

ASJC Scopus subject areas

  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Baseline serum Aspergillus galactomannan index in patients with hematologic malignancy and culture-documented invasive pulmonary aspergillosis: Is there a difference among Aspergillus species?'. Together they form a unique fingerprint.

Cite this